DAX6.050-3,4%  Dow12.119-2,2%  Euro1,24320,6% 
ESt502.069-2,4%  Nas2.748-2,8%  Öl98,82-2,8% 
TDax730,9-2,7%  Nikkei8.440-1,2%  Gold1.6264,2% 
Home > Aktien > Sequenom Aktie > Nachrichten zu Sequenom

Sequenom Aktie [WKN: A0J23S / ISIN: US8173374054]

Kurse + Charts + RealtimeNews + AnalysenFundamentalUnternehmenzugeh. WertpapiereAktion
Kurs + ChartChart (groß)News + AdhocBilanz/GuVTermineZertifikateDepot
Times + SalesChart-AnalyseAnalysenDividende/HVProfilOptionsscheineWatchlist
BörsenplätzeChartvergleichKursziele InsidertradesKnock-outsmyHome
OrderbuchRealtime StuttgartRSS FeedAnalyseim ForumFondsSenden
HistorischRealtime PushmyNews neu IR-DatenAnleihen
handeln

Hinweis

Auf dieser Seite finden Sie ALLE Nachrichten zur Sequenom IncShs . Links ausgesuchte Top-Nachrichten, rechts weitere Meldungen.

Newssuche

 GO 

ALLE Nachrichten zur Sequenom IncShs

16.03.10Sequenom verfehlt Analystenerwartungen, Aktie deutlich leichter
05.05.09Glancy Binkow & Goldberg LLP, Representing Investors Who Purchased Sequenom, Inc., Announces Class Action Lawsuit and Seeks to Recover Losses
01.05.09Coughlin Stoia Geller Rudman & Robbins LLP Files Class Action Suit against Sequenom, Inc.
01.05.09Johnson Bottini, LLP Files Class Action on Behalf of Purchasers of Sequenom, Inc.
30.04.09Law Offices of Howard G. Smith Announces Investigation On Behalf of Investors of Sequenom, Inc.
29.04.09SEQUENOM Reports First Quarter 2009 Financial Results
29.04.09SEQUENOM Announces Delay in Launch of SEQureDx Trisomy 21 Test
23.04.09SEQUENOM Announces Cost Cutting Initiative in Genetic Analysis Business
09.03.09Sequenom to Present at Two Investment Community Conferences in March
09.03.09Sequenom to Present at Two Investment Community Conferences in March
04.03.09Sequenom Adopts Share Purchase Rights Plan
03.03.09Sequenom Selects PDI to Provide Sales Team for Launch of Noninvasive Prenatal Screening Tests
18.02.09High-Throughput Genotyping of AML Patients for a Key Immune Receptor May Significantly Improve Treatment Outcome
11.02.09Sequenom Reports Fourth Quarter Financial Results
04.02.09Sequenom to Hold Fourth Quarter and Full Year 2008 Financial Results Conference Call on February 11
03.02.09Sequenom Announces Findings on Methylation Markers and RNA-SNP Markers as Presented at SMFM
29.01.09Sequenom Announces New Positive Data on Down Syndrome Detection and Unveils Breakthrough DNA Approach to Prenatal Diagnostics
28.01.09Sequenom Center for Molecular Medicine Collaborates with Obstetrix Medical Group to Provide Clinical Samples for LDT Validation Study
28.01.09Sequenom Terminates Exchange Offer to Acquire EXACT Sciences
27.01.09Sequenom Commences Exchange Offer to Acquire EXACT Sciences
26.01.09Sequenom Expands Molecular Diagnostics Portfolio with Acquisition of SensiGen
26.01.09Sequenom Names Allan T. Bombard, M.D., Chief Medical Officer
14.01.09Sequenom to Commence Exchange Offer to Acquire EXACT Sciences
13.01.09The Immune Tolerance Institute, Sequenom and the University of California, San Francisco to Develop Advanced Diagnostic Test for Severe Combined Immunodeficiency in Newborns
09.01.09Sequenom Proposes to Acquire EXACT Sciences for $1.50 Per Share or Approximately $41 Million
08.01.09Sequenom to Present at the 27th Annual J.P. Morgan Healthcare Conference on January 15
01.12.08Next-Generation Noninvasive Diagnostic Technology Shown to Accurately Detect Fetal Down Syndrome in First Trimester of Pregnancy
24.11.08New Noninvasive Prenatal Diagnostic Technology Allows Diagnosis of Inherited Diseases Such as Cystic Fibrosis Caused by Single Gene Mutations
17.11.08Sequenom Completes Acquisition of CLIA-Certified Laboratory
30.10.08Sequenom Reports 2008 Third Quarter Financial Results
30.10.08Xenomics Announces License Agreement with Sequenom for Prenatal Diagnostic Applications of Transrenal Nucleic Acid Technology
30.10.08Sequenom Announces Exclusive Licensing Agreement with Xenomics for Noninvasive Prenatal Diagnostics Using Transrenal DNA
28.10.08Sequenom Announces Launch of RNA-Based Noninvasive Aneuploidy (RNA) Study
08.10.08Sequenom to Hold 2008 Third Quarter Financial Results Conference Call on October 30
23.09.08Sequenom Announces Additional, Positive Results for Down Syndrome Test at Analyst Briefing
23.09.08Sequenom Announces Acquisition of CLIA-Certified Laboratory and Partnerships with Spectrum Health and Van Andel Research Institute
22.09.08Sequenom Announces Exclusive Licensing Agreement with Genomic Nanosystems for Digital PCR Technologies and Methods Patents
16.09.08Sequenom Acquires Exclusive License to Digital PCR and Other Noninvasive Prenatal Diagnostic Intellectual Property
02.09.08Sequenom to Present at September Investment Conferences and to Hold Analyst and Investor Briefing Event
05.08.08Sequenom Certifies McGill University and Genome Quebec Innovation Centre as First Center of Excellence

Anzeige

ANZEIGE

Seite: 123
Wie bewerten Sie diese Seite?
schlecht sehr gut
Problem mit dieser Seite?
Aktien Prime Standard: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z DAX MDAX Dow Jones EuroStoxx

Kontakt - Impressum - Werben - Presse

finanzen.net als Startseite - Sitemap - Arbeiten bei finanzen.net - RSS-Feeds - Datenschutz - Disclaimer - Nutzungsbedingungen


Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information. Verzögerung Deutsche Börse: 15 Min., Nasdaq, NYSE: 20 Min. © 1999-2012 finanzen.net GmbH

News Aktien Kurslisten Analysen Devisen Dollarkurs Fonds Zertifikate Optionsscheine Anleihen Rohstoffe Aktien kaufen Portfolio Links Aktien China Währungsrechner Gold kaufen CFD Aktienkurse Ölpreis Leitzins Heizölpreis IPO Börsenkurse Lexikon